Skip to main content
Reset
Show/Hide
Top menu InfoLep
About InfoLep
News & Events
e-learning.infoNTD.org
Main navigation InfoLep
Leprosy
[5]
Global and Regional Leprosy Situation
WHO Global Leprosy Strategy
ILEP Strategy
World Leprosy Day
Leprosy journals
Key topics
[8]
Leprosy and COVID-19
Diagnostic tests
Prevention of leprosy
[2]
Interventions to reduce transmission: post-exposure prophylaxis (PEP)
[3]
LPEP Program
PEP++ project
PEP4LEP 2.0 & PEP4LEP
Interventions to reduce transmission: vaccines
Rehabilitation & prevention of disability
[2]
Preventing leprosy-related disabilities in girls and boys
Self-care in leprosy
Leprosy Antibiotic Treatment
Stigma, discrimination & mental wellbeing
[4]
World Leprosy Day 2022
Gender
Mental wellbeing
SARI Project
Bioarchaeology of leprosy
PEP4LEP 2.0 & PEP4LEP
Toolkits
[6]
Guides on Stigma and Mental Wellbeing
[5]
Guide 1. What are health-related stigma and mental wellbeing?
[8]
1. What is stigma?
2. Why does stigma exist?
3. What are the causes of stigma?
4. Who stigmatises?
5. How does it feel to experience stigma?
6. What are the effects of stigma?
7. Effects of stigma and discrimination on mental wellbeing
Annex Guide 1
Guide 2. How to reduce the impact of stigma
[7]
1. From undetected disease to diagnosis to support
2. Individual-level interventions
3. Group-level interventions
4. Family-level interventions
5. Referral
6. Further reading
Annexes Guide 2
Guide 3. How to reduce sources of stigma
[6]
1. Background to the design of a stigma-reduction intervention
2. Identifying the sources of stigma
3. Targeting an intervention
4. Inclusion of affected persons and champions in interventions
5. Interventions by source type
Annexes Guide 3
Guide 4. How to assess health-related stigma and mental wellbeing
[9]
1. What is the purpose of the assessment?
2. What approach would best fit your purpose and context?
3. Quantitative assessment methods
4. Qualitative assessment methods
5. Assessments using mixed methods
6. Developing qualitative methods from scratch
7. How do you conduct a stigma assessment?
8. How to interpret and report your findings
Annexes Guide 4
Glossary
NTD Morbidity and Disability Toolkit
[16]
CHIEF
Clinical Profile
EMIC affected persons
EMIC-CS Community Stigma
Participation Scale
Patient Health Questionnaire (PHQ-9)
5-Question Stigma Indicators
Salsa Scale
SARI Stigma Scale
SDS Social Distance Scale
SRQ Self-reporting Questionnaire
Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
WGQ Washington Group Questions
WHODAS
WHOQOL-BREF
Health-related Perception Inquiry
Perception Study Toolkit (PST)
Zero Leprosy Toolkit
CBM's Community Mental Health Good Practice Guides
Prevention of Leprosy (SDR-PEP) Toolkit
Online courses
Ocular DB
Top menu InfoLep
About InfoLep
News & Events
e-learning.infoNTD.org
Visit our e-learning platform
Search resources
Search in Practical Materials, Publications, Organizations, Online Course and more
Author
Gidoh M
Namisato M
Kumano K
Goto M
Nogami R
Ozaki M
Commitee for standards on therapeutic usage of newquinolones
Journal Article
Download citation
Google Scholar
BibTeX
EndNote X3 XML
EndNote 7 XML
Endnote tagged
Marc
PubMed XML
PubMedId
RIS
Rtf
